324 related articles for article (PubMed ID: 62946)
1. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
[TBL] [Abstract][Full Text] [Related]
2. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
[TBL] [Abstract][Full Text] [Related]
5. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
6. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
[TBL] [Abstract][Full Text] [Related]
8. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
[TBL] [Abstract][Full Text] [Related]
9. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report).
Somner AR
Lancet; 1980 May; 1(8179):1182-3. PubMed ID: 6103997
[No Abstract] [Full Text] [Related]
10. Present status of chemotherapy for tuberculosis.
Grosset JH
Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
[TBL] [Abstract][Full Text] [Related]
11. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
12. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
Tubercle; 1977 Mar; 58(1):1-8. PubMed ID: 325837
[TBL] [Abstract][Full Text] [Related]
13. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
[TBL] [Abstract][Full Text] [Related]
14. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
16. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
17. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Baba H; Schinkai A; Izuchi R; Azuma Y
Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
[No Abstract] [Full Text] [Related]
18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
20. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]